D.B. Root & Company, LLC Abb Vie Inc. Transaction History

D.B. Root & Company, LLC

$296 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	BUY	$144.61 - $166.54 $61,170 - $70,446	423 Added 4.22%	10,458 $1.67 Million
Q4 2022 Jan 27, 2023	BUY	$138.31 - $165.87 $7,607 - $9,122	55 Added 0.55%	10,035 $0
Q3 2022 Oct 26, 2022	SELL	$134.21 - $153.93 $35,834 - $41,099	-267 Reduced 2.61%	9,980 $1.34 Million
Q2 2022 Jul 21, 2022	BUY	$137.62 - $174.96 $10,183 - $12,947	74 Added 0.73%	10,247 $1.57 Million
Q1 2022 May 06, 2022	BUY	$131.98 - $163.75 $12,934 - $16,047	98 Added 0.97%	10,173 $1.65 Million
Q4 2021 Feb 01, 2022	SELL	$107.43 - $135.93 $61,987 - $78,431	-577 Reduced 5.42%	10,075 $1.36 Million
Q3 2021 Oct 22, 2021	BUY	$106.4 - $120.78 $9,363 - $10,628	88 Added 0.83%	10,652 $1.15 Million
Q2 2021 Jul 28, 2021	SELL	$105.21 - $117.21 $78,486 - $87,438	-746 Reduced 6.6%	10,564 $1.19 Million
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $102 - $112	1 Added 0.01%	11,310 $1.22 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $56,423 - $76,177	-701 Reduced 5.84%	11,309 $1.21 Million
Q3 2020 Oct 22, 2020	SELL	$85.91 - $100.83 $55,583 - $65,237	-647 Reduced 5.11%	12,010 $1.05 Million
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $39,473 - $52,820	538 Added 4.44%	12,657 $1.24 Million
Q1 2020 Apr 29, 2020	BUY	$64.5 - $97.79 $35,797 - $54,273	555 Added 4.8%	12,119 $923,000
Q4 2019 Jan 14, 2020	BUY	$72.13 - $90.25 $9,088 - $11,371	126 Added 1.1%	11,564 $1.02 Million
Q3 2019 Oct 29, 2019	BUY	$62.98 - $75.72 $43,078 - $51,792	684 Added 6.36%	11,438 $866,000
Q2 2019 Jul 19, 2019	SELL	$65.7 - $83.98 $37,908 - $48,456	-577 Reduced 5.09%	10,754 $782,000
Q1 2019 Apr 12, 2019	BUY	$77.14 - $90.79 $62,869 - $73,993	815 Added 7.75%	11,331 $913,000
Q4 2018 Jan 25, 2019	BUY	$77.85 - $96.01 $11,366 - $14,017	146 Added 1.41%	10,516 $969,000
Q3 2018 Nov 05, 2018	BUY	$88.91 - $98.84 $9,424 - $10,477	106 Added 1.03%	10,370 $981,000
Q2 2018 Jul 25, 2018	BUY	$89.78 - $106.23 $18,315 - $21,670	204 Added 2.03%	10,264 $951,000
Q1 2018 May 02, 2018	BUY	$92.01 - $123.21 $194,877 - $260,958	2,118 Added 26.67%	10,060 $952,000
Q4 2017 Feb 22, 2018	BUY	$89.56 - $98.21 $711,285 - $779,983	7,942	7,942 $768,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.B. Root & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on D.B. Root & Company, LLC with notifications on news.

Account